Home/Filings/4/0001493152-21-006270
4//SEC Filing

Hogge Gary S. 4

Accession 0001493152-21-006270

CIK 0000876343other

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 5:00 PM ET

Size

5.5 KB

Accession

0001493152-21-006270

Insider Transaction Report

Form 4
Period: 2021-03-15
Hogge Gary S.
SVP,Clinical & Medical Affairs
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2021-03-15+419,500419,500 total
    Exercise: $2.43Exp: 2031-03-15Common Shares (419,500 underlying)
Footnotes (1)
  • [F1]One quarter of the options shall vest on March 15, 2022 and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.

Documents

1 file

Issuer

Lineage Cell Therapeutics, Inc.

CIK 0000876343

Entity typeother

Related Parties

1
  • filerCIK 0001771711

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 5:00 PM ET
Size
5.5 KB